Astria Therapeutics, Inc.

Direct answer

Astria Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ATXS.

Astria Therapeutics, Inc. is a biopharmaceutical company based in Boston, Massachusetts, established in 2008. The firm specializes in identifying, advancing, and bringing to market treatments for uncommon and specialized allergic and immunological disorders across the United States. Its leading experimental drug, STAR-0215, is a monoclonal antibody that targets and inhibits plasma kallikrein. This candidate is...

Can you invest in Astria Therapeutics, Inc.?

Yes. Astria Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ATXS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Astria Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.